We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Nicovape Q50 - Classic Tobacco (50 mg/mL) – Notification ID: VG-2024-NTF-00241, Liber Pharmaceuticals Limited, CON-1375
Product name
Nicovape Q50 - Classic Tobacco (50 mg/mL) – Notification ID: VG-2024-NTF-00241
Sponsor name
Liber Pharmaceuticals Limited
Consent start
Consent no.
CON-1375
Duration
The consent is effective from 1 July 2025 until the earlier of: (a) 7 July 2025 (inclusive); or (b) when Liber receives notice in writing of the Secretary’s decision in relation to an application for consent to supply.
Standard
One or more of: Section 20; Paragraph (c) in Column 2, Item 2 in the table at subsection 22(1); Items 4, 5 & 6 in the table at subsection 22(1); Item 7 in the table at subsection 23(1); Paragraph (b) in Column 2, Item 8 in the table at subsection 23(1); Paragraph (c) in Column 2, Item 2 in the table at subsection 24(1); Item 6 in the table at subsection 24(1); Section 29; and Paragraph (c) in Column 3, Item 1 of Schedule 1. of Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021
Non-compliance with standard
Products do not comply with some requirements of the enhanced product standard
for therapeutic vaping goods.
Conditions imposed
Liber must take every reasonable effort to inform each pharmacist, medical
practitioner or nurse practitioner (or the practice manager or purchasing
officer of that person) who possesses any quantity of the Goods at any time
while this consent is effective that:
a) the Goods do not conform with an applicable standard, being TGO 110, from 1
July 2025;
b) the TGA is currently assessing an application from Liber to permit
importation and supply of the Goods, despite that non-compliance; and
c) until that application is assessed, the Goods should not be supplied to
patients.
Import, Supply, &/or Export
supply
Therapeutic product type
Other therapeutic goods non-approved